A complete application in a minute
Tailored resume and cover letter, ready to send.
The Breast Cancer Translational Research Group at the University of Pennsylvania seeks a Research Specialist C to conduct translational preclinical breast cancer research using organoids, patient-derived xenograft (PDX) models, and cell culture systems.
The successful candidate will work with investigators to evaluate experimental therapies, including radiotherapies, and investigate treatment response and mechanisms of cancer cell death.
The University of Pennsylvania, the largest private employer in Philadelphia, is a world-renowned leader in education, research, and innovation. This historic, Ivy League school consistently ranks among the top 10 universities in the annual U.S. News & World Report survey. Penn has 12 highly-regarded schools that provide opportunities for undergraduate, graduate and continuing education, all influenced by Penn's distinctive interdisciplinary approach to scholarship and learning. As an employer Penn has been ranked nationally on many occasions with the most recent award from Forbes who named Penn one of America's Best Large Employers in 2023.
Penn offers a unique working environment within the city of Philadelphia. The University is situated on a beautiful urban campus, with easy access to a range of educational, cultural, and recreational activities. With its historical significance and landmarks, lively cultural offerings, and wide variety of atmospheres, Philadelphia is the perfect place to call home for work and play.
The University offers a competitive benefits package that includes excellent healthcare and tuition benefits for employees and their families, generous retirement benefits, a wide variety of professional development opportunities, supportive work and family benefits, a wealth of health and wellness programs and resources, and much more.
Research Specialist C
Research Specialist C
The Breast Cancer Translational Research Group seeks a Research Specialist C to conduct translational preclinical breast cancer research using organoids, patient-derived xenograft (PDX) models, and cell culture systems. The successful candidate will work with investigators to evaluate experimental therapies, including radiotherapies, and investigate treatment response and mechanisms of cancer cell death. This position requires hands‑on experience with animal studies and mammalian cell culture, the ability to design and conduct experiments independently, and careful attention to experimental design, documentation, and reproducibility. There is an expectation that the candidate can design entire animal studies with little oversight, including those investigating novel compounds and novel radiotracers. This scientist will work closely with both the PennRad and PennMedicine Biobank teams.
Bachelor of Science and 3 to 5 years of experience or equivalent combination of education and experience is required.
Position is Contingent upon Grant Funding
Philadelphia, Pennsylvania
Perelman School of Medicine
$58,506.00 - $67,794.79 Annual Rate Salary offers are made based on the candidate's qualifications, experience, skills, and education as they directly relate to the requirements of the position, and in alignment with salary ranges based on external market data for the job's level. Internal organization and peer data at Penn are also considered.
The University of Pennsylvania is an equal opportunity employer. Candidates are considered for employment without regard to race, color, sex, sexual orientation, religion, creed, national origin (including shared ancestry or ethnic characteristics) , citizenship status, age, disability, veteran status or any class protected under applicable federal, state or local law .
Background checks may be required aft